It all starts with a diagnosis

Our vision at Asthma + Lung UK is for a world where everyone has healthy lungs. When people are left struggling to breathe, getting them the right treatment starts with early and accurate diagnosis. Dr Erika Kennington, Head of Research and Innovation, tells us more about Asthma + Lung UK’s £2 million investment in improving diagnosis and why better diagnosis tools, techniques, and approaches are key to saving the nation’s lung health.

When you’re unwell, the first step towards feeling better is an accurate diagnosis of what’s going wrong.

People who have difficulty breathing often wait years for a formal diagnosis or worse, never receive one at all. In part, this is because society doesn’t always take breathlessness seriously, or consider lung problems as worthy of attention as other diseases.

Even when people do approach their GPs or visit a healthcare professional, diagnosis is still too slow. That’s because tests and procedures to detect and diagnose conditions haven’t evolved or improved for far too long.

The first step to better lung health

Tests are often inaccurate, unpleasant, invasive, costly, and unavailable outside of specialist hospital settings. Asthma, one of the UK’s most common lung conditions, is both under and over diagnosed. Idiopathic pulmonary fibrosis (IPF), bronchiectasis and chronic obstructive pulmonary disease (COPD) – conditions that have a huge impact on people’s quality of life – can be misdiagnosed or left unexplained for years.

This, and the lack of effective diagnostic procedures means people don’t receive the care they need. Their lungs and lung function can significantly deteriorate in the months and years they wait before getting onto the right treatment. Once your lungs are damaged, it is extremely difficult to reverse that damage. Treatments today rarely bring people back to full health but rather slow further decline and improve the quality-of-life left. That's why it's so important to stop that decline as soon as possible, and that starts with a speedy and accurate diagnosis.

Our investment in improving diagnosis

So, Asthma + Lung UK is investing £2 million in exceptional science and product innovation to support earlier, simpler, faster, kinder, and more accurate diagnosis of lung conditions. Scientists and innovators have until the end of January to apply for funding for projects that will lead to the development of new or improved diagnostic products.

Nobody should be left without a diagnosis that explains why their lungs aren’t working as they should. Nor should the process of receiving that explanation be convoluted and hard work.

If we are serious about reducing respiratory deaths and ill health by 20% in five years, research needs to start with the very first step to treating lung conditions, improving diagnosis, so that people have access to the very best care and treatments from day one.

Find out more about our research grants here.



 

You may also like

A man with short dark hair and a dark moustache is wearing black glasses, a white lab coat and orange gloves. He's stood in a research lab holding some samples up to the light
Research

Help us end the diagnosis delay and improve the future of lung health research

Dr Erika Kennington, Head of Research and Innovation at Asthma + Lung UK talks us through why early diagnosis is crucial for people living with lung conditions now but also the future of lung health research.
A woman with shoulder length dark hair wearing glasses, a white lab coat and purple latex gloves is leaning over a microscope and looking directly at the camera.
Research

Research is bridging the gap between everyday health and science

From exploring the genetic cues behind asthma to studying how air pollution affects the lungs, research is leading the way to better lung health.
Woman and a microscope
Research

Our new research strategy: reducing respiratory morbidity and mortality

Dr Samantha Walker tells us about Asthma + Lung UK’s mission to reduce respiratory morbidity and mortality by 20% over the next 5 years through a big focus on research and innovation.